BACKGROUND: @entity3 ( @entity3 ) appears to be changing preoperative treatment and referral patterns for sporadic, nonfamilial, @entity3018 , @entity459 ( @entity459 ). METHODS: The American Association of Clinical Endocrinologists membership was surveyed by mail (n=1406 members) regarding physician practices and surgical referral patterns for @entity459 . RESULTS: Seven hundred eighty-eight respondents (56%) practiced 17.0+/-0.4 years and referred 63%+/-1% of @entity1 with @entity459 for operation. Most endocrinologists (90%) used localizing studies before surgical referral (sestamibi, ultrasound scanning, @entity1136 / @entity4214 scanning, magnetic resonance imaging, computed tomography). Respondents identified symptoms, @entity460 homeostasis, bone density, health status, age, and general anesthesia risk as the most important considerations for surgical referral. Most respondents (79%) indicated that @entity3 availability would increase the number of @entity1 who were referred for operation (P<.001), although most of the respondents stated that @entity3 would change the extent and duration of preoperative evaluations (P<.001). Respondents in practice for fewer years were more likely to refer @entity1 for @entity3 (P<.001) and minimize preoperative evaluation (P<.05). Endocrinologists who had a @entity1 with a complication after traditional parathyroidectomy were more likely to embrace @entity3 (P<.05). CONCLUSIONS: @entity3 availability decreases the extent and duration of preoperative evaluation while decreasing the time from diagnosis to referral. @entity3 also lowers the endocrinologists' surgical referral threshold for @entity459 , although it emphasizes the perceived shortcomings of traditional parathyroidectomy that are held by many physicians.

The impact of minimally invasive parathyroidectomy on the way endocrinologists treat XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1136 :: ('MESH:D013667', 'Chemical') :: ['technetium'] @entity459 :: ('MESH:D049950', 'Disease') :: ['primary hyperparathyroidism', 'PHPT'] @entity3018 :: ('MESH:D009377', 'Disease') :: ['non-multiple endocrine neoplasia'] @entity4214 :: ('MESH:D013793', 'Chemical') :: ['thallium'] @entity3 :: ('MESH:D009362', 'Disease') :: ['Minimally-invasive parathyroidectomy', 'MIP'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium']
@entity459 :: (MESH:D049950,Disease) :: ['primary hyperparathyroidism']
